ART4 and infection: Geisbert et al. [84] generated a VSV-LASV vaccine expressing full-length glycoprotein from the Lassa Josiah strain (lineage IV), which protected cynomolgus macaques against infection with the LASV Josiah strain when administered as a single-dose vaccine 28 days before challenge.